People who use methamphetamine are more likely to have health conditions, mental illness, and substance use disorders than people who do not use the drug, according to a new study by researchers at the Center for Drug Use and HIV/HCV Research (CDUHR) at NYU School of Global Public Health.
Pixabay/Pexels.com Cancer a word no one wants to hear in the same sentence as their own name or the name of a loved one. As a physician, it s my job to not only treat cancer, but also prevent it.
Earlier this month, Dr. Eva Chalis joined me for a discussion on “Your Radio Doctor,” a medical talk show that airs every Sunday morning at 10 a.m. on Talk Radio 1210 WPHT. Dr. Chalis is a Professor of Obstetrics and Gynecology at NYU Long Island School of Medicine and the immediate past President of the American College of Obstetricians and Gynecologists. She had just returned from the
Share this article
Share this article
NEW YORK, May 19, 2021 /PRNewswire/ Cancer drugs capable of weakening the body s immune defenses are no more likely to increase the risk of Covid-19 infection or death than breast cancer therapies that do not undermine the immune system, a new study shows. Researchers say the results challenge initial concerns that such treatments, which poison cancer cells, were too dangerous to continue during the pandemic.
Led by researchers at NYU Langone Health and its Perlmutter Cancer Center, the new investigation involving over 3,000 women treated for breast cancer at the height of the pandemic in New York City showed that only 64, or 2 percent, contracted the virus. Of this group, 10 died from COVID-19, a number the study authors say is low and expected for this age group, regardless of cancer.